Press Releases

Below are some of the ways that ATCC strives to fulfill it's mission to acquire, authenticate, preserve, produce, develop and share biological materials for the advancement and application of scientific knowledge. You may contact us with comments or inquiries regarding these announcements.

2014 Releases

ATCC to Provide Proficiency Testing Programs through Partnership with LGC

ATCC Strengthens its Senior Management Team

ATCC Adds New Customer-driven Format to its Quality Control Standards Portfolio

ATCC Announces New Appointments to its Leadership Team

ATCC and bioMérieux Collaborate to Deliver Accurate Identification of Industrial Microorganisms

ATCC Adds ISO 13485:2003 Certification to its Quality Management Program

ATCC Teams with CDC and Thermo Fisher Scientific on Public Health RT-PCR Assay.

ATCC will feature the largest portfolio of infectious disease research reagents at asm2014.

ATCC expands its portfolio of Certified Reference Materials to include Quantitative Mycoplasma DNA

ATCC Showcases Extensive Cancer Research Solutions for the Creation of Biologically Relevant In Vitro Cancer Models at AACR Annual Meeting 2014. 

ATCC will Feature New Cell-based Solutions that are Designed to Support Automated Screening Technologies at SLAS 2014. 

Biomātrica and ATCC Sign a Licensing Agreement for the Supply of Room Temperature DNA and RNA Stabilization Reagents.

2013 Releases

ATCC showcases comprehensive portfolio of cell-based tools and reagents for basic, translational, and clinical research during the 2013 ASCB Annual Meeting.

ATCC and Evercyte form a partnership to develop and distribute immortalized human cells and cell lines. 

ATCC Examined the Importance of High-Quality Controls in Assay Design and Development During the Association for Molecular Pathology (AMP) 2013 Annual Meeting

ATCC Announces Creation of Biomaterial Contributor Network

2012 Releases

August 21st 2012 — Corporate Announcement

ATCC Now Offers the “Big Six” E. coli Strains for Food Safety Testing 
Representative strains from all six non-O157 Shiga toxin producing E. coli serogroups are available for use as positive and negative controls for food quality control assays.

Agreement with Life Technologies Corporation Allows ATCC to Make Green Fluorescent Protein (GFP)-based Materials Available to the Broad Research Community

ATCC Annouces Agreements Providing Access to Promega Corporation's NanoLuc™, GloSensor™, and HaloTag® Technologies

New MTA and Deposit Policy

ATCC U.VA. Collaboration to Foster Biotech Discovery

ATCC SDO Releases Ground-Breaking Standard for Human Cell Lines

2011 Releases

ATCC Awarded NCI Funding to Establish a Physical Sciences-Oncology Centers (PS-OC) Bioresource Core Facility (PBCF)

Promega Partners with ATCC to Offer New Cell Systems for Biologics Drug Discovery

ATCC and iPS Academia Japan, Inc. (AJ) Enter into Patent License Agreement to Distribute iPS Cells and iPS Cell-Derived Cells

ATCC and Stemgent, Inc. Announce Collaborative Research Agreement to Advance Development of Novel Stem Cell Reagents and Pluripotent Cells